API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore. Ebitda turned positive at Rs 39.3 crore. The company also became debt-free after repaying Rs 1,050 crore.